BridgeBio Pharma, Inc.
BBIO$67.32▲ 2.81% 24h
BridgeBio Pharma, Inc.BBIO$67.32
+$8.27(+14.00%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$13.05B
P/E ratio
—
EPS (diluted)
$-3.78
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$502.08M
Net income
$-69,000
Net margin
-0.0%
Gross margin
—
Dividends & financials
BridgeBio Pharma, Inc. (BBIO) reported revenue of $502.08M and net income of $-69,000, or $-3.78 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.